Letters Drug pricing

PPRS is not NICE

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39339.451262.3A (Published 20 September 2007) Cite this as: BMJ 2007;335:578
  1. Andrea Messori, coordinator
  1. Laboratory of Pharmacoeconomics, Azienda Careggi, 50134 Florence, Italy
  1. andreamessori{at}interfree.it

    Some of Burnand's comments on Iheanacho's article are astonishing.1 If the mission of any national health system is maximising health, this mission is pursued by assuming that spending on a drug buys not the milligrams of the active substance but the clinical …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe